Le Lézard
Classified in: Health
Subjects: HEALTH, MISCELLANEOUS

Health Coalition Exposes Significantly Higher Costs & Irregularities in Kingston Hospital Cataract Surgery Privatization: New Report


KINGSTON, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The KHC's new report, A Clear-Eyed Analysis of Cataract Surgery Privatization, examined two years, November 24, 2021, to September 30, 2023, of Kingston Health Sciences Centre (KHSC) privatizing cataract surgeries to a private for-profit chain, Focus Medical Ancillary (FMA). The cost to the health care system was $2,036,779, a 56% increase over what it would have cost to perform the same services in the public hospital.

The data was compiled from documents released after Freedom of Information requests. "The private cataract surgery contract means $2 million is lost to the public health system. Instead, these funds were used to build up a more expensive for-profit health care provider," commented Ross Sutherland, KHC co-chair and author of the report. "On top of the increased cost, the $2 million spent supporting a more expensive private facility is ultimately outside the control of the hospital or government. It is subject to the workings of the market. The company could go bankrupt or move on, either way taking the benefit of that public investment."

"The 56% increase in cost over doing the surgeries in the public hospital is public money that could have been spent opening unused hospital operating rooms, retaining and expanding staff, or funding cataract surgeries in a smaller, nearby, regional hospital, such as in Napanee."

The Coalition also found that the KHSC-FMA contract lacks transparency, an ongoing problem with public money being spent on for-profit corporations. The private corporate partner is not clear. Proper extensions in the contract are in doubt. Is it a temporary "occupancy agreement", or a more in-depth long-term privatization? And, what options, like opening closed hospital operating rooms, were considered?

Possible conflicts of interests in the creation of the privatization contract were identified and the approval of the contract appears to violate the procurement directives under the Public Sector Accountability Act.

"Without transparency there cannot be public accountability and trust that decisions are being made in the public's interest not for private for-profit interests," argued Joan Jardin, the other KHC Co-Chair. "To begin to establish trust in the system, and stop the waste of public money, the private cataract surgery contract needs to be ended as soon as possible."

The full report can be found at: https://www.ontariohealthcoalition.ca/index.php/release-report-health-coalition-exposes-significantly-higher-costs-irregularities-in-kingston-hospital-cataract-surgery-privatization-new-report/

For more information: Ross Sutherland, Kingston Health Coalition co-chair (613) 532-7846 or Joan Jardin Kingston Health Coalition co-chair (613) 305-2716.



These press releases may also interest you

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...



News published on and distributed by: